YWP
BSTC

YorkBridge Wealth Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

YorkBridge Wealth Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-500
Closed -$25K – 940
2016
Q4 		$25K Buy
+500
New +$24K 0.01% 445

Other funds holding BSTC

JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

YorkBridge Wealth Partners's BSTC Position: Q1 2017 in Review

YorkBridge Wealth Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 500 shares — an estimated $25K sold.

YorkBridge Wealth Partners first reported a position in BSTC in Q4 2016 and held it in 1 quarter. The position peaked at $25K in Q4 2016. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

  • YorkBridge Wealth Partners reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 500 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $25K.
  • YorkBridge Wealth Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and held it in 1 quarter.
  • YorkBridge Wealth Partners's BioSpecifics Technologies Corp. position peaked at $25K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on YorkBridge Wealth Partners's 13F filing for Q1 2017, filed 5 May 2017.